Morphle Labs raises $5 mn in Series A funding led by Inflexor Ventures
Summary
Morphle Labs has raised $5 million in Series A funding led by Inflexor Ventures. The company will use the capital to expand globally, hire more talent, scale manufacturing, and strengthen its technology and IP portfolio. Its flagship product, RoboTome, automates a critical step in cancer diagnostics, and its companion product MorphoLens digitizes pathology slides for remote workflows. The company already operates in more than 30 countries and is increasing its commercial footprint in the US and Europe. The raise supports its move into the go-to-market phase for its robotics, AI, and medical device platform.
Funding
Amount
$5.0M
Total raised
Date
November 25, 2025
Announcement date
Investors
Inflexor Ventures
Lead investors
Company
-
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected